AccuQuest Hearing Center, Inc. – Trademark Portfolio

Entity Type: 03

AccuQuest Hearing Center, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 37 (Building & Construction) across 4 Nice Classification classes. The owner is based in Hoffman Estates, IL.

2700 West Higgins Road, Suite 120

Hoffman Estates, IL 601692006

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

AccuQuest Hearing Center, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

37
Building & Construction (1 filing)

Building construction; repair; installation services

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Frequently Asked Questions

How many trademarks does AccuQuest Hearing Center, Inc. have?

AccuQuest Hearing Center, Inc. has 2 U.S. trademarks filed with the USPTO.

What trademark classes does AccuQuest Hearing Center, Inc. file in?

AccuQuest Hearing Center, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 37 (Building & Construction), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.

What is AccuQuest Hearing Center, Inc.'s trademark registration success rate?

AccuQuest Hearing Center, Inc. has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.